ES2616022T3 - Composiciones farmacéuticas de curcumina - Google Patents
Composiciones farmacéuticas de curcumina Download PDFInfo
- Publication number
- ES2616022T3 ES2616022T3 ES11824671.9T ES11824671T ES2616022T3 ES 2616022 T3 ES2616022 T3 ES 2616022T3 ES 11824671 T ES11824671 T ES 11824671T ES 2616022 T3 ES2616022 T3 ES 2616022T3
- Authority
- ES
- Spain
- Prior art keywords
- oil
- surfactant
- solvent
- propylene glycol
- curcumin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 title abstract 8
- 229940109262 curcumin Drugs 0.000 title abstract 4
- 235000012754 curcumin Nutrition 0.000 title abstract 4
- 239000004148 curcumin Substances 0.000 title abstract 4
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 8
- 239000003921 oil Substances 0.000 abstract 6
- 235000019198 oils Nutrition 0.000 abstract 6
- 239000002904 solvent Substances 0.000 abstract 4
- 239000004094 surface-active agent Substances 0.000 abstract 4
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 3
- 229930195729 fatty acid Natural products 0.000 abstract 3
- 239000000194 fatty acid Substances 0.000 abstract 3
- -1 fatty acid triglycerides Chemical class 0.000 abstract 3
- 235000011187 glycerol Nutrition 0.000 abstract 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 abstract 2
- WITKSCOBOCOGSC-UHFFFAOYSA-N 2-dodecanoyloxypropyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCCCC WITKSCOBOCOGSC-UHFFFAOYSA-N 0.000 abstract 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 abstract 1
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- AOBORMOPSGHCAX-UHFFFAOYSA-N Tocophersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-UHFFFAOYSA-N 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 235000006708 antioxidants Nutrition 0.000 abstract 1
- 235000019864 coconut oil Nutrition 0.000 abstract 1
- 239000003240 coconut oil Substances 0.000 abstract 1
- 150000005690 diesters Chemical class 0.000 abstract 1
- 235000019441 ethanol Nutrition 0.000 abstract 1
- FMMOOAYVCKXGMF-MURFETPASA-N ethyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC FMMOOAYVCKXGMF-MURFETPASA-N 0.000 abstract 1
- 229940031016 ethyl linoleate Drugs 0.000 abstract 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical class CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 abstract 1
- FMMOOAYVCKXGMF-UHFFFAOYSA-N linoleic acid ethyl ester Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC FMMOOAYVCKXGMF-UHFFFAOYSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 abstract 1
- 239000008389 polyethoxylated castor oil Substances 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
- 229920001451 polypropylene glycol Polymers 0.000 abstract 1
- 229950008882 polysorbate Drugs 0.000 abstract 1
- 229920000136 polysorbate Polymers 0.000 abstract 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/121—Ketones acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hospice & Palliative Care (AREA)
- Toxicology (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Una composición farmacéutica estable de curcumina que comprende aceite, disolvente, tensioactivo y, opcionalmente, antioxidante, estando la proporción del aceite con respecto al disolvente, del tensioactivo con respecto al disolvente y del tensioactivo con respecto a la curcumina en el intervalo de 0,83 a 10, de 1 a 60 y de 3 a 15, respectivamente, con curcumina en el intervalo del 2 al 20 % p/p, en la que (i) el aceite se selecciona entre: (1) aceite de coco fraccionado, triglicérido caprílico/cáprico o un aceite que contiene triglicéridos de ácidos grasos, preferentemente triglicéridos de ácidos grasos de cadena media; (2) miristato de isopropilo, palmitato de isopropilo, linoleato de etilo o un aceite que contiene ésteres de oleato de etilo de ácidos grasos y alcanoles monovalentes; (3) dicaprilato de propilenglicol, dilaurato de propilenglicol o un aceite que contiene diésteres de ácidos grasos de propilenglicol; (ii) el tensioactivo se selecciona entre polisorbato, vitamina E TPGS y Cremophor®; y (iii) el disolvente se selecciona entre glicofurol, polietilenglicol, glicerol, polipropilenglicol, propilenglicol, glicerina, N-metil-2-pirrolidona y alcohol etílico o mezcla de los mismos.
Description
Claims (1)
-
imagen1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2553MU2010 | 2010-09-15 | ||
| INMU25532010 | 2010-09-15 | ||
| PCT/IB2011/053974 WO2012035480A2 (en) | 2010-09-15 | 2011-09-12 | Pharmaceutical compositions of curcumin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2616022T3 true ES2616022T3 (es) | 2017-06-09 |
Family
ID=45832022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES11824671.9T Active ES2616022T3 (es) | 2010-09-15 | 2011-09-12 | Composiciones farmacéuticas de curcumina |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US9474727B2 (es) |
| EP (1) | EP2616053B1 (es) |
| ES (1) | ES2616022T3 (es) |
| WO (1) | WO2012035480A2 (es) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019046978A1 (es) * | 2017-09-05 | 2019-03-14 | Universidad De Chile | Método para obtener nanoestructuras con carotenoides y nanoestructuras obtenidas |
| RU2808324C2 (ru) * | 2019-02-11 | 2023-11-28 | Джозеф ХАЛСТЕД | Терапевтически применимые высокодозированные безводные растворы куркуминоидов |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE202012013584U1 (de) * | 2012-10-22 | 2018-01-15 | Briu Gmbh | Pharmazeutische Formulierung enthaltend Curcumin |
| US9517249B2 (en) | 2012-11-26 | 2016-12-13 | Access Business Group International Llc | Antioxidant dietary supplement and related method |
| US11185507B2 (en) | 2014-10-08 | 2021-11-30 | Boston Biopharm Inc. | Compositions and methods for increasing the bioavailability of one or more compounds |
| US10085951B2 (en) | 2014-12-11 | 2018-10-02 | Designs For Health, Inc. | Curcuminoid formulations and related methods of treatment |
| ES2895851T3 (es) | 2016-04-01 | 2022-02-22 | Trioptotec Gmbh | Dispersión de fotosensibilizador y uso de la misma |
| CN106667912A (zh) * | 2017-02-08 | 2017-05-17 | 何德海 | 一种姜黄素纳米乳液的制备方法 |
| CN110538167A (zh) * | 2018-05-29 | 2019-12-06 | 冉文萍 | 姜黄素组合物及其制备方法和用途 |
| CN110960516B (zh) * | 2018-09-27 | 2023-01-06 | 广州汝丽多食品科技有限公司 | 一种姜黄素复合物及其制备方法 |
| AU2019365596B2 (en) | 2018-10-23 | 2025-07-03 | Lyrus Life Sciences Pvt. Ltd. | Formulation comprising water soluble particles of a non-curcuminoid and a curcuminoid |
| WO2020181256A1 (en) * | 2019-03-06 | 2020-09-10 | Renibus Therapeutics, Inc. | Novel tetrahydrocurcumin compositions, methods of making, and methods of using the same |
| WO2021016576A1 (en) * | 2019-07-25 | 2021-01-28 | Skin Medicinals LLC | Topical compositions |
| CN110693833A (zh) * | 2019-10-31 | 2020-01-17 | 上海交通大学医学院附属新华医院 | 一种用超浓乳液制备纳米姜黄素复合制剂的方法 |
| AU2021373070B2 (en) | 2020-11-09 | 2023-08-24 | Albert Einstein College Of Medicine | Transdermal delivery formulations |
| CN115176989A (zh) * | 2022-07-12 | 2022-10-14 | 河南中大恒源生物科技股份有限公司 | 一种透明姜黄素油溶液及其制备方法和应用 |
| WO2025107048A1 (pt) * | 2023-11-21 | 2025-05-30 | Makrofarma Química Farmacêutica Ltda | Composição farmacêutica a base de curcuminóides |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8784881B2 (en) * | 2004-03-05 | 2014-07-22 | Board Of Regents, The University Of Texas System | Liposomal curcumin for treatment of diseases |
| CN100352430C (zh) | 2005-03-09 | 2007-12-05 | 山东大学 | 姜黄素自微乳化制剂及其制备方法 |
| PL1993365T3 (pl) | 2006-03-06 | 2013-10-31 | Univ California | Preparaty z biodostępnych kurkuminoidów do leczenia choroby alzheimera oraz innych zaburzeń powiązanych z wiekiem |
| WO2010010431A1 (en) | 2008-07-24 | 2010-01-28 | National Institute Of Pharmaceutical Education And Research | Self-nano-emulsifying curcuminoids composition with enhanced bioavailability |
| US8329757B2 (en) * | 2008-10-14 | 2012-12-11 | Charlesson, Llc | Curcumin analog compositions and related methods |
| CN101627969B (zh) * | 2009-07-30 | 2011-06-29 | 浙江工业大学 | 一种姜黄素自乳化给药系统及其制备 |
-
2011
- 2011-09-12 US US13/822,539 patent/US9474727B2/en active Active
- 2011-09-12 WO PCT/IB2011/053974 patent/WO2012035480A2/en not_active Ceased
- 2011-09-12 ES ES11824671.9T patent/ES2616022T3/es active Active
- 2011-09-12 EP EP11824671.9A patent/EP2616053B1/en active Active
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019046978A1 (es) * | 2017-09-05 | 2019-03-14 | Universidad De Chile | Método para obtener nanoestructuras con carotenoides y nanoestructuras obtenidas |
| RU2808324C2 (ru) * | 2019-02-11 | 2023-11-28 | Джозеф ХАЛСТЕД | Терапевтически применимые высокодозированные безводные растворы куркуминоидов |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2616053A2 (en) | 2013-07-24 |
| US20130225689A1 (en) | 2013-08-29 |
| WO2012035480A2 (en) | 2012-03-22 |
| WO2012035480A3 (en) | 2012-07-05 |
| EP2616053B1 (en) | 2016-11-02 |
| EP2616053A4 (en) | 2014-01-15 |
| US9474727B2 (en) | 2016-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2616022T3 (es) | Composiciones farmacéuticas de curcumina | |
| HRP20140445T1 (hr) | Farmaceutski sastav za inhibitor proteaze virusnog hepatitisa c | |
| AR074391A1 (es) | Composicion farmaceutica de un potente inhibidor de hcv para su administracion oral | |
| ES2617683T3 (es) | Composiciones oftálmicas basadas en ácidos grasos Omega-3 y Omega-6 poliinsaturados | |
| RU2012130421A (ru) | Кожная композиция, включающая аналог витамина d и смесь растворителя и поверхностно-активных веществ | |
| MX2017009489A (es) | Composicion auto-emulsionante de acido graso ?3. | |
| ES2539861T3 (es) | Formulaciones en emulsión de clevidipina que contienen agentes antimicrobianos | |
| RU2011148140A (ru) | Самомикроэмульгирующаяся оральная фармацевтическая композиция, содержащая гидрофильное лекарственное средство, и способ ее приготовления | |
| JP2013515018A5 (es) | ||
| PE20080390A1 (es) | Composiciones antioxidantes liquidas monofasicas solubles en lipidos y procesos para elaborar las composiciones | |
| RU2013126259A (ru) | Фармацевтическая композиция таксоидов | |
| RU2011139638A (ru) | Сублингвальная фармацевтическая композиция, содержащая нейтральное масло | |
| RU2015134141A (ru) | Композиции твердых растворов и их применение при хроническом воспалении | |
| CL2013002611A1 (es) | Composicion de complejo oral que contiene un nucleo de ester de acido graso omega-3,una primera capa hidrofobica, una segunda capa que contiene: i) rosuvastatina y ii) alcohol polivinilico, copolimero alcohol polivinilico-polietilen glicol o mezclas; metodo de preparacion. | |
| PH12016500100B1 (en) | Self-emulsifying composition of omega3 fatty acid | |
| RU2018136873A (ru) | Сложные эфиры для лечения офтальмологических воспалительных заболеваний | |
| CO6501136A2 (es) | Composiciones que comprenden una mezcla de aceite de ácido graso y un tensoactivo, y métodos y usos de las mismas | |
| JP2012524771A5 (es) | ||
| JP2014509655A5 (es) | ||
| CA2864118A1 (en) | Formulations of bendamustine | |
| RU2015144013A (ru) | Липидные композиции рацекадотрила | |
| MX2015011074A (es) | Composicion que comprende un compuesto lipido, un triglicerido y un tensioactivo, y metodos de uso de la misma. | |
| RU2015102597A (ru) | Липидные композиции рацекадотрила | |
| CL2011001225A1 (es) | Formulacion farmaceutica en solucion acuosa que comprende desde 1% hasta 5% (p/v) de una sal de diclofenaco, desde 3% hasta 30% (p/v) de al menos un polioxialquilen ester de hidroxido de acido graso y un co-solvente seleccionado de etanol, propanol, glicerol, propilenglicol entre otros. | |
| ES2561207T3 (es) | Emulsión grasa para alimentar artificialmente a pacientes gravemente enfermos de cuidados intensivos |